Medibase
EN VI JA

DAV data · Drug recalls

Drugs recalled in Vietnam (DAV recall decisions)

Source: dav.gov.vn Last synced: 2026-05-21 Recall notices: 84

84 notices found. Showing 51–84.

Document № Drug Registration № Level Type Source
6058/QLD-CL
2021-05-28
Atisalbu oral solution
Official Letter No. 6058/QLD-CL notifying the recall of a drug with a level 3 violation (Atisalbu oral solution (Salbutamol 2mg/5ml))
— Level 3 Quality violation
615/QLD-CL
2021-02-01
Tobraquin
Official Letter No. 615/QLD-CL on the notification of the recall of Tobraquin
— — Other
35/QLD-CL
2021-01-07
B - COMENE injection
Official Letter No. 35/QLD-CL on the notification of the recall of a drug with a level 2 violation (B - COMENE injection, Reg. No.: VN-18188-14, Batch no.: 190811; Mfg. date: 11/08/2019; Exp.: 10/08/2022)
VN-18188-14 Level 2 Quality violation
18286/QLD-CL
2020-12-11
Bronzoni soft capsules
Official Letter No. 18286/QLD-CL on the notification of the recall of a drug with a level 3 violation (Bronzoni soft capsules)
— Level 3 Quality violation
17570/QLD-CL
2020-11-27
Sedtyl
Official Letter No. 17570/QLD-CL on the notification of the recall of Sedtyl, batch no. 02L19
— — Other
17463/QLD-CL
2020-11-25
Sedtyl
Official Letter No. 17463/QLD-CL on the notification of the recall of Sedtyl, batch 03M19
— — Other
17330/QLD-CL
2020-11-23
Atibutrex
Official Letter No. 17330/QLD-CL on the notification of the recall of Atibutrex due to a level 2 violation
— Level 2 Quality violation
16984/QLD-CL
2020-11-17
Dacodex soft capsules
Official Letter No. 16984/QLD-CL on the notification of the recall of a drug with a level 3 violation (Dacodex soft capsules)
— Level 3 Quality violation
16746/QLD-CL
2020-11-10
Protamine Choay 1000 U.A.H/ml solution for injection
Official Letter No. 16746/QLD-CL on the quality of Protamine Choay 1000 U.A.H/ml solution for injection
— — Other
15052/QLD-CL
2020-09-17
Trimoxtal
Official Letter No. 15052/QLD-CL on the notification of the recall of Trimoxtal, Reg. No.: VD-20158-13
VD-20158-13 — Other
12222/QLD-CL
2020-08-05
Detracyl 250 sugar-coated tablets
Official Letter No. 12222/QLD-CL on the suspension from circulation of a drug failing to meet quality standards: Detracyl 250 sugar-coated tablets (Mephenesin 250mg), Reg. No.: VD-20186-13, Batch no.: 61100718
VD-20186-13 — Quality violation
11924/QLD-CL
2020-07-31
Genpharmason
Official Letter No. 11924/QLD-CL on the notification of the recall of a drug with a level 2 violation (Genpharmason)
— Level 2 Quality violation
11444/QLD-CL
2020-07-24
Navacarzol 5mg tablets
Official Letter No. 11444/QLD-CL on the notification of the recall of a drug with a quality violation (Navacarzol 5mg tablets)
— — Quality violation
6526/QLD-CL
2020-05-26
Captopril 25mg
Official Letter No. 6526/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Captopril 25mg)
— — Quality violation
5555/QLD-CL
2020-05-06
Dekasiam
Official Letter No. 5555/QLD-CL on the suspension from circulation of Dekasiam, which fails to meet quality standards
— — Quality violation
3425/QLD-CL
2020-04-09
Incepban 400 Chewable Tablet chewable tablets
Official Letter No. 3425/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Incepban 400 Chewable Tablet chewable tablets (Albendazole 400mg))
— — Quality violation
2899/QLD-CL
2020-03-29
Alsoben tablets
Official Letter No. 2899/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Alsoben tablets)
— — Quality violation
2865/QLD-CL
2020-03-27
Chloramphenicol 250 mg
Official Letter No. 2865/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Chloramphenicol 250 mg)
— — Quality violation
2808/QLD-CL
2020-03-26
B-Comene injection
Official Letter No. 2808/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (B-Comene injection)
— — Quality violation
2240/QLD-CL
2020-03-11
Tre Viet granules
Official Letter No. 2240/QLD-CL on the suspension from circulation of Tre Viet granules, which fail to meet quality standards
— — Quality violation
838/QLD-CL
2020-01-31
Buclapoxime film-coated tablets
Official Letter No. 838/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Buclapoxime film-coated tablets (Cefpodoxime Proxetil Tablets USP 200 mg))
— — Quality violation
235/QLD-CL
2020-01-14
Young II Captopril Tablet tablets
Official Letter No. 235/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Young II Captopril Tablet tablets (Captopril 25mg))
— — Quality violation
20787/QLD-CL
2019-12-12
LIV-Z Tablets tablets
Official Letter No. 20787/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (LIV-Z Tablets tablets)
— — Quality violation
19942/QLD-CL
2019-11-28
Young II Captopril
Official Letter No. 19942/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Young II Captopril)
— — Quality violation
19781/QLD-CL
2019-11-26
Ceteco Melocen 7
Official Letter No. 19781/QLD-CL on the suspension from circulation of Ceteco Melocen 7.5, which fails to meet quality standards
— — Quality violation
19664/QLD-CL
2019-11-22
Aciclovir
Official Letter No. 19664/QLD-CL on the recall of Aciclovir, which fails to meet quality standards
— — Quality violation
16814/QLD-CL
2019-10-02
Ranitidine
Official Letter 16814/QLD-CL on the recall of Ranitidine-containing drugs with NDMA impurity levels exceeding the permitted limit
— — Other
16457/QLD-CL
2019-09-24
Clavophynamox 1000
Official Letter 16457/QLD-CL on the recall of Clavophynamox 1000, which fails to meet quality standards
— — Quality violation
6346/QLD-CL
2019-04-26
Cetirizine tablets 10mg
Official Letter 6346/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Cetirizine tablets 10mg)
— — Quality violation
3828/QLD-CL
2019-03-25
Diuresin SR
Official Letter No. 3828/QLD-CL suspending from circulation a drug failing to meet quality standards (Diuresin SR (Indapamide 1.5mg))
— — Quality violation
883/QLD-CL
2019-01-25
Peridom-M film-coated tablets
Official Letter No. 883/QLD-CL suspending from circulation a drug failing to meet quality standards (Peridom-M film-coated tablets)
— — Quality violation
884/QLD-CL
2019-01-25
Chymomedi
Official Letter No. 884/QLD-CL suspending from circulation a drug failing to meet quality standards (Chymomedi (Chymotrypsin 21 microkatals))
— — Quality violation
—
2018-09-14
Koreamin injection
Suspension from circulation of a drug failing to meet quality standards (Koreamin injection)
— — Quality violation
—
2018-07-06
Unicet film-coated tablets
Suspension from circulation of a drug failing to meet quality standards (Unicet film-coated tablets (Cetirizin hydroclorid 10mg))
— — Quality violation
DAV

Reference data. Decision number, drug name, registration number and violation level are parsed automatically from each notice title, so some notices may leave these fields blank. Verify against the signed recall decision PDF before relying on it for legal purposes.

Services by MTC

Need help with pharmacovigilance?

Handled by MTC Consulting & Trading Co., Ltd, the team behind Medibase — medibase@mtcorp.vn

About this data

The Drug Administration of Vietnam (DAV) issues recall decisions for drugs pulled from the market — for a quality violation, a voluntary recall, or a withdrawal of the marketing authorisation. Quality violations are graded level 1–3 (level 1 is the most serious). Compiled from the DAV cn89 listing.